ECSP056093A - Proceso para la preparación de 2-cianopirrolidinas n-sustituidas - Google Patents
Proceso para la preparación de 2-cianopirrolidinas n-sustituidasInfo
- Publication number
- ECSP056093A ECSP056093A EC2005006093A ECSP056093A ECSP056093A EC SP056093 A ECSP056093 A EC SP056093A EC 2005006093 A EC2005006093 A EC 2005006093A EC SP056093 A ECSP056093 A EC SP056093A EC SP056093 A ECSP056093 A EC SP056093A
- Authority
- EC
- Ecuador
- Prior art keywords
- reacting
- resulting compound
- preparation
- halogen
- isolation
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 4
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 abstract 3
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 238000002955 isolation Methods 0.000 abstract 2
- VLJNHYLEOZPXFW-BYPYZUCNSA-N L-prolinamide Chemical compound NC(=O)[C@@H]1CCCN1 VLJNHYLEOZPXFW-BYPYZUCNSA-N 0.000 abstract 1
- -1 N- (N'-substituted glycyl) -2-cyano-pyrrolidine Chemical class 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000001412 amines Chemical class 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 230000018044 dehydration Effects 0.000 abstract 1
- 238000006297 dehydration reaction Methods 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Pyrrole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
La presente invención se refiere a un proceso para la preparación de una N-(glicilo N'-sustituido)-2-ciano-pirrolidina, el cual comprende cuando menos: (a) hacer reaccionar, en la presencia de dimetil-formamida, un compuesto de la fórmula (V): en donde, de manera independiente unos de otros, X1 y X3 son halógeno; X2 es halógeno, OH, O-C(=O)-CH2X3, -O-SO2-alquilo (de 1 a 8 átomos de carbono), u -O-SO2-(arilo), con L-prolinamida, seguido por:(b) hacer reaccionar el compuesto resultante, sin aislamiento, con un agente de deshidratación, opcionalmente seguido por: (c) hacer reaccionar, en la presencia de una base, el compuesto resultante, sin aislamiento, con una amina apropiada; y(d) recuperar el compuesto resultante en forma libre o en forma de sal de adición de ácido.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0308854A GB0308854D0 (en) | 2003-04-16 | 2003-04-16 | Organic compounds |
| GB0311836A GB0311836D0 (en) | 2003-05-22 | 2003-05-22 | Process for the manufacture of organic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP056093A true ECSP056093A (es) | 2006-03-01 |
Family
ID=33301223
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EC2005006093A ECSP056093A (es) | 2003-04-16 | 2005-10-12 | Proceso para la preparación de 2-cianopirrolidinas n-sustituidas |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US7375238B2 (es) |
| EP (1) | EP1620396B1 (es) |
| JP (1) | JP4672647B2 (es) |
| KR (1) | KR101192538B1 (es) |
| AR (1) | AR044019A1 (es) |
| AU (2) | AU2004230245B2 (es) |
| BR (1) | BRPI0409471B8 (es) |
| CA (1) | CA2520128C (es) |
| CL (1) | CL2004000804A1 (es) |
| CO (1) | CO5700735A2 (es) |
| CY (1) | CY1116008T1 (es) |
| DK (1) | DK1620396T3 (es) |
| EC (1) | ECSP056093A (es) |
| ES (1) | ES2531084T3 (es) |
| HR (1) | HRP20150163T1 (es) |
| IL (1) | IL170887A (es) |
| IS (1) | IS2979B (es) |
| MA (1) | MA27765A1 (es) |
| MX (1) | MXPA05011073A (es) |
| MY (1) | MY139476A (es) |
| NO (1) | NO333251B1 (es) |
| NZ (1) | NZ542899A (es) |
| PE (2) | PE20081293A1 (es) |
| PL (1) | PL1620396T3 (es) |
| PT (1) | PT1620396E (es) |
| RU (1) | RU2369598C2 (es) |
| SG (1) | SG160212A1 (es) |
| SI (1) | SI1620396T1 (es) |
| TW (1) | TWI359135B (es) |
| WO (1) | WO2004092127A1 (es) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20081293A1 (es) | 2003-04-16 | 2008-11-04 | Novartis Ag | Procedimiento de preparacion de compuestos 2(s)-cianopirrolidina n-(n'-glicilo sustituida) |
| DK3366283T3 (da) | 2004-01-20 | 2021-11-22 | Novartis Ag | Direkte sammenpresningsformulering og fremgangsmåde |
| GT200600008A (es) | 2005-01-18 | 2006-08-09 | Formulacion de compresion directa y proceso | |
| EP1888562B1 (en) | 2005-04-22 | 2014-06-18 | Alantos Pharmaceuticals Holding, Inc. | Dipeptidyl peptidase-iv inhibitors |
| US20080279932A1 (en) * | 2005-08-04 | 2008-11-13 | Jean-Louis Reber | Compounds |
| WO2008066083A1 (fr) * | 2006-11-29 | 2008-06-05 | Mitsubishi Tanabe Pharma Corporation | Procédé de production d'un dérivé de n-(n'-glycyle substitué)-2-cyanopyrrolidine |
| WO2008084383A2 (en) * | 2007-01-10 | 2008-07-17 | Medichem, S.A. | Process for preparing vildagliptin |
| CZ2008512A3 (cs) | 2008-08-26 | 2010-03-10 | Zentiva, A. S | Zpusob prípravy vysoce cistého vildagliptinu |
| EA034049B1 (ru) * | 2009-07-31 | 2019-12-23 | КРКА, д.д., НОВО МЕСТО | Гранулят, включающий вилдаглиптин, способ его получения и фармацевтическая композиция |
| HUP0900638A2 (en) | 2009-10-07 | 2011-05-30 | Egyt Gyogyszervegyeszeti Gyar | Adducts of inorganic salts basea on vildaelitpin applicable for preparation of pharmaceutical compositions |
| IT1400714B1 (it) | 2010-07-06 | 2013-06-28 | Chemelectiva S R L | Processo ed intermedi per la preparazione di un principio attivo. |
| HU231050B1 (hu) | 2010-08-19 | 2020-02-28 | Egis Gyógyszergyár Nyrt. | Eljárás gyógyszerhatóanyag előállítására |
| ITMI20112224A1 (it) | 2011-12-06 | 2013-06-07 | Chemelectiva S R L | Nuovo processo ed intermedi per la sintesi di vildagliptin |
| WO2013179300A2 (en) * | 2012-05-04 | 2013-12-05 | Megafine Pharma (P) Ltd. | A process for the preparation of vildagliptin and its intermediate thereof |
| CN103922986B (zh) * | 2013-01-16 | 2017-02-15 | 上海彩迩文生化科技有限公司 | 维大列汀及其类似物、中间体及其制备方法和应用 |
| WO2015145467A1 (en) * | 2014-03-28 | 2015-10-01 | Laurus Labs Private Limited | An improved process for preparing vildagliptin |
| WO2021234430A1 (en) | 2020-05-17 | 2021-11-25 | Lotus International Pte. Ltd. | Modified release dosage form comprising vildagliptin and process for manufacturing the same |
| WO2022003405A1 (en) | 2020-07-03 | 2022-01-06 | Savoi Guilherme | One-pot process to obtain a pyrrolidine-2-carbonitrile intermediate compound and industrial scale telescopic process to prepare (2s)-1-[n-(3-hydroxyadamantan-1-yl)glycyl]-2-pyrrolidinecarbonitrile (vildagliptin) using same |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5510369A (en) * | 1994-07-22 | 1996-04-23 | Merck & Co., Inc. | Pyrrolidine thrombin inhibitors |
| TW492957B (en) * | 1996-11-07 | 2002-07-01 | Novartis Ag | N-substituted 2-cyanopyrrolidnes |
| CO5150173A1 (es) * | 1998-12-10 | 2002-04-29 | Novartis Ag | Compuestos n-(glicilo sustituido)-2-cianopirrolidinas inhibidores de peptidasa de dipeptidilo-iv (dpp-iv) los cuales son efectivos en el tratamiento de condiciones mediadas por la inhibicion de dpp-iv |
| US6380398B2 (en) * | 2000-01-04 | 2002-04-30 | Novo Nordisk A/S | Therapeutically active and selective heterocyclic compounds that are inhibitors of the enzyme DPP-IV |
| JP2003520849A (ja) * | 2000-01-24 | 2003-07-08 | ノボ ノルディスク アクティーゼルスカブ | 酵素ｄｐｐ−ｉｖの阻害剤であるｎ−置換２−シアノピロールおよび−ピロリン |
| TW583185B (en) * | 2000-06-13 | 2004-04-11 | Novartis Ag | N-(substituted glycyl)-2-cyanopyrrolidines and pharmaceutical composition for inhibiting dipeptidyl peptidase-IV (DPP-IV) or for the prevention or treatment of diseases or conditions associated with elevated levels of DPP-IV comprising the same |
| JP2002265439A (ja) * | 2001-03-08 | 2002-09-18 | Mitsubishi Pharma Corp | シアノピロリジン誘導体およびその医薬用途 |
| PE20081293A1 (es) | 2003-04-16 | 2008-11-04 | Novartis Ag | Procedimiento de preparacion de compuestos 2(s)-cianopirrolidina n-(n'-glicilo sustituida) |
-
2004
- 2004-04-14 PE PE2007000421A patent/PE20081293A1/es not_active Application Discontinuation
- 2004-04-14 AR ARP040101251A patent/AR044019A1/es not_active Application Discontinuation
- 2004-04-14 PE PE2004000370A patent/PE20050021A1/es not_active Application Discontinuation
- 2004-04-15 PT PT04727557T patent/PT1620396E/pt unknown
- 2004-04-15 AU AU2004230245A patent/AU2004230245B2/en not_active Ceased
- 2004-04-15 MX MXPA05011073A patent/MXPA05011073A/es active IP Right Grant
- 2004-04-15 ES ES04727557T patent/ES2531084T3/es not_active Expired - Lifetime
- 2004-04-15 RU RU2005135331/04A patent/RU2369598C2/ru active
- 2004-04-15 SG SG200716949-3A patent/SG160212A1/en unknown
- 2004-04-15 NZ NZ542899A patent/NZ542899A/en not_active IP Right Cessation
- 2004-04-15 KR KR1020057019568A patent/KR101192538B1/ko not_active Expired - Fee Related
- 2004-04-15 WO PCT/EP2004/003980 patent/WO2004092127A1/en not_active Ceased
- 2004-04-15 PL PL04727557T patent/PL1620396T3/pl unknown
- 2004-04-15 US US10/552,835 patent/US7375238B2/en not_active Expired - Fee Related
- 2004-04-15 DK DK04727557.3T patent/DK1620396T3/en active
- 2004-04-15 CA CA2520128A patent/CA2520128C/en not_active Expired - Fee Related
- 2004-04-15 CL CL200400804A patent/CL2004000804A1/es unknown
- 2004-04-15 MY MYPI20041383A patent/MY139476A/en unknown
- 2004-04-15 HR HRP20150163TT patent/HRP20150163T1/hr unknown
- 2004-04-15 BR BRPI0409471A patent/BRPI0409471B8/pt not_active IP Right Cessation
- 2004-04-15 JP JP2006505132A patent/JP4672647B2/ja not_active Expired - Lifetime
- 2004-04-15 EP EP04727557.3A patent/EP1620396B1/en not_active Expired - Lifetime
- 2004-04-15 TW TW093110566A patent/TWI359135B/zh not_active IP Right Cessation
- 2004-04-15 SI SI200432220T patent/SI1620396T1/sl unknown
-
2005
- 2005-09-15 IL IL170887A patent/IL170887A/en active IP Right Grant
- 2005-10-12 EC EC2005006093A patent/ECSP056093A/es unknown
- 2005-10-19 MA MA28559A patent/MA27765A1/fr unknown
- 2005-11-03 CO CO05112189A patent/CO5700735A2/es not_active Application Discontinuation
- 2005-11-07 NO NO20055226A patent/NO333251B1/no not_active IP Right Cessation
- 2005-11-10 IS IS8122A patent/IS2979B/is unknown
-
2008
- 2008-05-22 AU AU2008202278A patent/AU2008202278A1/en not_active Abandoned
-
2015
- 2015-02-18 CY CY20151100168T patent/CY1116008T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP056093A (es) | Proceso para la preparación de 2-cianopirrolidinas n-sustituidas | |
| CR7080A (es) | Sales tartrato de 5,8,14-triazatetraciclo [10.3.1.02,11.04,9] hexadeca-2(11),3,5,7,9-pentaeno y composiciones farmaceuticas de las mismas. | |
| AR064833A1 (es) | Un procedimiento para la preparacion de vildagliptin | |
| BRPI0500585A (pt) | Processo para a sìntese de ivabradina e sais de adição desta com um ácido farmaceuticamente aceitável | |
| GR1003874B (el) | Μεθοδος για την παρασκευη καθαρης σιταλοπραμης | |
| CO6270330A2 (es) | 2-fluoro-2`-desoxitetrahidrouridinas como inhibidores de citidina desaminasa | |
| SG165154A1 (en) | Ester compound and medical use thereof | |
| EA200970171A1 (ru) | Производные n-(аминогетероарил)-1н-индол-2-карбоксамидов, их получение и их применение в терапии | |
| CY1113873T1 (el) | Παραγωγα hydroxybenzamide σαν παραγοντες καταστολης της hsp90 | |
| CO6241150A2 (es) | Procedimiento de preparacion de combretastatina | |
| HU0201083D0 (es) | ||
| EA200200939A1 (ru) | Способ получения циталопрама | |
| DE602006008962D1 (de) | Verfahren zur herstellung von valsartan | |
| IL180357A0 (en) | An isolated atomoxetine impurity, processes for the preparation of atomoxetine impurities and their use as reference standards | |
| NO20005301L (no) | Pyrrolidiner som inhibitorer av neuraminidaser | |
| TNSN05261A1 (en) | Process for the preparation of n-substituted 2-cyanopyrrolidines | |
| AR248396A1 (es) | Procedimiento para la obtencion de 1, 5-diaril pirazoles utiles como antiinflamatorios y compuestos intermediarios para su uso exclusivo en el procedimiento. | |
| CR8456A (es) | Inhibidores heterociclil amino de 11- beta- hidroxiesteroide deshidrogenasa tipo 1 | |
| BR0308617A (pt) | Processo para derivados de triterpeno | |
| MX2025007744A (es) | Proceso para preparacion de cloruro de sulfamoilo | |
| TW200719921A (en) | Hair treating agent | |
| BR0207895A (pt) | Processo para a preparação de citalopram | |
| DE50206142D1 (de) | Verfahren zur herstellung von 1,3-disubstituierten 2-nitroguanidinen | |
| CY1107067T1 (el) | Αλατα δικαρφοξυλικου οξεως της βεναζεπριλης και παρασκευη της βεναζεπριλης μεσω αυτων | |
| BRPI0409644A (pt) | processo para a preparação de nicotinaldeìdos |